TScan Therapeutics, Inc. (TCRX)
NASDAQ: TCRX · Real-Time Price · USD
3.940
-0.180 (-4.37%)
At close: Nov 21, 2024, 4:00 PM
3.910
-0.030 (-0.76%)
After-hours: Nov 21, 2024, 4:00 PM EST
TScan Therapeutics Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Net Income | -111.3 | -89.22 | -66.22 | -48.63 | -26.13 | -13.66 |
| Depreciation & Amortization | 4.68 | 5.36 | 5.14 | 3.33 | 1.23 | 0.52 |
| Loss (Gain) From Sale of Assets | - | - | - | - | 0 | 0.08 |
| Loss (Gain) From Sale of Investments | -3.18 | -1.07 | - | - | - | - |
| Stock-Based Compensation | 8.34 | 5.21 | 4.55 | 2.52 | 0.52 | 0.24 |
| Other Operating Activities | 0.7 | 0.76 | 0.26 | - | - | - |
| Change in Accounts Payable | 0.37 | -0.05 | 0.53 | 0.01 | 1.13 | 0.16 |
| Change in Unearned Revenue | -9.36 | 11.89 | -9.03 | -6.54 | 19.44 | - |
| Change in Other Net Operating Assets | 2.59 | 5.77 | -1.73 | 0.63 | 0.79 | 0.14 |
| Operating Cash Flow | -107.18 | -61.36 | -66.5 | -48.68 | -3.02 | -12.52 |
| Capital Expenditures | -3.41 | -3.15 | -4.23 | -9.94 | -4.24 | -1.25 |
| Investment in Securities | -74.59 | -57.61 | - | - | - | - |
| Investing Cash Flow | -77.99 | -60.76 | -4.23 | -9.94 | -4.24 | -1.25 |
| Long-Term Debt Issued | - | - | 29.35 | - | - | - |
| Net Debt Issued (Repaid) | - | - | 29.35 | - | - | - |
| Issuance of Common Stock | 34.82 | 43.13 | 0.33 | 89.94 | 0.29 | 0.01 |
| Other Financing Activities | 128.27 | 92.32 | -0.32 | - | - | - |
| Financing Cash Flow | 163.09 | 135.44 | 29.36 | 189.67 | 0.29 | 34.81 |
| Net Cash Flow | -22.08 | 13.33 | -41.37 | 131.05 | -6.97 | 21.04 |
| Free Cash Flow | -110.58 | -64.5 | -70.73 | -58.62 | -7.26 | -13.77 |
| Free Cash Flow Margin | -1181.18% | -306.45% | -522.56% | -578.03% | -669.22% | - |
| Free Cash Flow Per Share | -2.07 | -1.35 | -2.94 | -5.03 | -7.93 | -35.75 |
| Cash Interest Paid | 3.01 | 3 | 0.66 | - | - | - |
| Levered Free Cash Flow | -71.11 | -41.83 | -42.84 | -33.43 | -5.85 | - |
| Unlevered Free Cash Flow | -68.79 | -39.48 | -42.1 | -33.43 | -5.85 | - |
| Change in Net Working Capital | 3.72 | -11.51 | 5.92 | -1.07 | -13.04 | - |
Source: S&P Capital IQ. Standard template.
Financial Sources.